First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting antibiotic-resistant lung infections...
Tokenized IP platform built to enable access, utility, and engagement with Pineapple branded proprietary assets LOS ANGELES, CA, July 14,...
LANGHORNE, Pa., July 14, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of...
Borvo Medical to showcase innovative EVAC™ system at Society of Neurointerventional Surgery Annual MeetingMOUNTAIN VIEW, Calif., July 14, 2025 (GLOBE...
Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025 Expanding payer coverage...
Kennewick, WA, July 14, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a pioneer in Precision Radionuclide TherapyTM (PRnT) solutions,...
WATERTOWN, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,...
HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on July...
July 14, 2025 Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)...
TAMPA, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group Inc. (OTC: FAGI) today announced the formation of Qubitera...
Company also announces new 500-patient SUMMIT RISE study at the Society of NeuroInterventional Surgery annual meetingSAN MATEO, Calif., July 14,...
Groundbreaking and major precedent setting milestone as first global shipment, via USA Controlled Substances import permit, of naturally occurring Psilocybin...
MILAN, July 14, 2025 /PRNewswire/ -- n6 is proud to announce a strategic partnership with SeqCenter, who is launching a...
Montreal, Quebec--(Newsfile Corp. - July 14, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a...